Devon Medical Products gets FDA marketing approval for extriCARE 3600 NPWT pump and foam kit

Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration (FDA) 510(k) clearance to market its extriCARE® 3600 NPWT pump and foam dressing kit.

The extriCARE® 3600 NPWT pump and foam kit are intended for use on wounds with large amounts of exudate, including wounds of critical nature. The products were designed for use in acute care and post-acute care settings, as well as skilled nursing facilities. Features of the extriCARE® 3600 include a 24-hour continuous, rechargeable battery, a rotatable back-mount for securing the device to hospital bed rails and IV poles, simple pressure settings between 40-200mmHg of pressure, and various alarms signaling air leakage, low battery, and other errors. The device currently utilizes a 400cc disposable canister, and a 1,000cc canister is in development.

"This regulatory approval is a significant step for Devon Medical Products as it opens the door for us to treat a broader range of wounds commonly found in institutional settings," says Chip Ross, president of Devon Medical Products. "We added this larger NPWT pump and a foam wound dressing kit to help complete our NPWT product line and provide wound care professionals with the technology they need to manage all types of wounds. We are proud to now offer a complete line of NPWT pumps, dressings, and accessories at a fraction of the cost of many of our competitors."

Devon Medical Products is showcasing the extriCARE® 3600 pump and foam dressing kits at the 46th Annual Wound, Ostomy and Continence Nurses Society™ Conference (booth #754) in Nashville, Tennessee this week. Various clinical experts are on hand to demonstrate Devon Medical Products' entire NPWT product line, including the portable extriCARE® 2400 and various-sized NPWT dressings, as well as its line of compression therapy products for the management of lymphedema.

Source:

Devon Medical Products, Inc.

Advertisement

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Researchers report challenges in reducing tetanus mortality